**Specifications table**TableSubject area*Cardiac arrest.*More specific subject area*Epidemiology of cardiac arrest.*Type of data*Tables and figures.*How data was acquired*Data analysis from the National Patient Registry (NPR) and the Swedish Registry of Cardiopulmonary Resuscitation (SRCR).*Data format*Analyzed.*Experimental factors*Data was analyzed to investigate whether comorbidity is associated with outcome in out-of-hospital cardiac arrest (OHCA).*Experimental features*Nationwide retrospective and population-based cohort study of patients with bystander witnessed OHCA.*Data source location*A nationwide cohort study in Sweden.*Data accessibility*The analyzed data are presented in this article.*Related research article*G. Hirlekar, M. Jonsson, T. Karlsson et al. Comorbidity and survival in out-of-hospital cardiac arrest. In press.*

**Value of the data**•The data provides information about how ICD-10 codes were used to create the categories in Charlson Comorbidity Index (CCI).•The data provides information of association between comorbidity and return of spontaneous circulation (ROSC).•The data provides information of the baseline characteristics of patients found in VF/VT.•The data provides comparison of patients with complete data and patients with missing data.•The data shows association between comorbidity and survival depending on when the comorbidity condition was identified.

1. Data {#s0005}
=======

The data contains information of how ICD-10 codes were used to create the categories in Charlson Comorbidity Index (CCI) as shown in [Table 1](#t0005){ref-type="table"} [@bib2]. Baseline characteristics of patients found in VF/VT are shown in [Table 2](#t0010){ref-type="table"}. Comparison of baseline characteristics of cases with and without complete data are shown in [Table 3](#t0015){ref-type="table"}. The association between missingness and other baseline characteristics, CCI and survival for all patients are shown in [Table 4](#t0020){ref-type="table"}. The relation between comorbidity and the chance of any return of spontaneous circulation (ROSC) is shown in [Fig. 1](#f0005){ref-type="fig"} and the corresponding figure for ROSC at hospital admission is shown in [Fig. 2](#f0010){ref-type="fig"}. Association between various aspects of comorbidity and 30-day survival among all patients with complete cases on all baseline characteristics (no missing) is shown in [Fig. 3](#f0015){ref-type="fig"}. In [Fig. 4](#f0020){ref-type="fig"}, [Fig. 5](#f0025){ref-type="fig"}, [Fig. 6](#f0030){ref-type="fig"}, we present the association between comorbidity and 30-day survival in relation to the time of identification of the comorbidity condition, as follows: Patients for whom comorbidity condition were identified 3--5 years before OHCA ([Fig. 4](#f0020){ref-type="fig"}); first identified within 1 year before OHCA ([Fig. 5](#f0025){ref-type="fig"}); and comorbidity condition within 1 year before OHCA irrespective of identification 1--5 years before OHCA ([Fig. 6](#f0030){ref-type="fig"}).Table 1Charlson comorbidity index according to ICD-10 codes.Table 1**DiseaseICD 10Weight point***Myocardial infarction*(I21.x, I22.x, I25.2),1*Congestive heart failure*(I09.9, I11.0, I13.0, I13.2, I25.5, I42.0, I42.5--I42.9, I43.x, I50.x, P29.0)1*Peripheral vascular disease*(I70.x, I71.x, I73.1, I73.8, I73.9, I77.1, I79.0, I79.2, K55.1, K55.8, K55.9, Z95.8, Z95.9)1*Cerebrovascular disease*(G45.x, G46.x, H34.0, I60.x--I69.x)1*Dementia*(F00.x--F03.x, F05.1, G30.x, G31.1)1*Chronic pulmonary disease*(I27.8, I27.9, J40.x--J47.x, J60.x--J67.x, J68.4, J70.1, J70.3)1*Rheumatic disease*(M05.x, M06.x, M31.5, M32.x--M34.x, M35.1, M35.3, M36.0)1*Peptic ulcer disease*(K25.x--K28.x)1*Mild liver disease*(B18.x, K70.0--K70.3, K70.9, K71.3--K71.5, K71.7, K73.x, K74.x, K76.0, K76.2--K76.4, K76.8, K76.9, Z94.4)1 (0 if also moderate or severe liver disease)*Diabetes without chronic complications*(E10.0, E10.1, E10.6, E10.8, E10.9, E11.0, E11.1, E11.6, E11.8, E11.9, E12.0, E12.1, E12.6, E12.8, E12.9, E13.0, E13.1, E13.6, E13.8, E13.9, E14.0, E14.1, E14.6, E14.8, E14.9)1 (0 if also diabetes with chronic complications)*Diabetes with chronic complications*(E10.2--E10.5, E10.7, E11.2--E11.5, E11.7, E12.2--E12.5, E12.7, E13.2-- E13.5, E13.7, E14.2--E14.5, E14.7)2*Hemiplegia/paraplegia*(G04.1, G11.4, G80.1, G80.2, G81.x, G82.x, G83.0--G83.4, G83.9)2*Renal disease*(I12.0, I13.1, N03.2--N03.7, N05.2-- N05.7, N18.x, N19.x, N25.0, Z49.0-- Z49.2, Z94.0, Z99.2)2*Cancer*(C00.x--C26.x, C30.x--C34.x, C37.x-- C41.x, C43.x, C45.x--C58.x, C60.x-- C76.x, C81.x--C85.x, C88.x, C90.x--C97.x)2 (0 if also metastatic carcinoma)Moderate or severe liver disease(I85.0, I85.9, I86.4, I98.2, K70.4, K71.1, K72.1, K72.9, K76.5, K76.6, K76.7)3*Metastatic carcinoma*(C77.x--C80.x)6*AIDS/HIV*(B20.x--B22.x, B24.x)6**Maximum possible score29**Table 2Baseline characteristics of VF/VT patients.Table 2**All patients(*n*=3,468)Alive at 30 days*p*-valueYesNo(*n*=1,098)(*n*=2,370)Year of OHCA:**0.03[\*](#tbl2fnStar){ref-type="table-fn"}2011693 - 20.0210 - 19.1483 - 20.42012696 - 20.1202 - 18.4494 - 20.82013676 - 19.5216 - 19.7460 - 19.42014671 - 19.3214 - 19.5457 - 19.32015732 - 21.1256 - 23.3476 - 20.1**OHCA during daytime 8 a.m. to 8 a.m.** (87/181)[\*\*](#tbl2fnStarStar){ref-type="table-fn"}2,281 - 71.3773 - 76.51,508 - 68.9\<0.0001**Age, years**69 (50,84)64 (45,79)71 (54,86)\<0.0001**Female sex**656 - 18.9200 - 18.2456 - 19.20.48**OHCA at home** (2/0)2,020 - 58.3464 - 42.31,556 - 65.7\<0.0001**CPR before arrival of EMS** (5/7)2,784 - 80.6953 - 87.21,831 - 77.5\<0.0001**Mechanical chest compression** (83/144)1,313 - 40.5290 - 28.61,023 - 46.0\<0.0001**Cardiac aetiology** (50/115)2,830 - 85.7898 - 85.71,932 - 85.71.00**Treatment:**Adrenalin (33/15)2,734 - 79.9532 - 50.02,202 - 93.5\<0.0001Intubation (18/31)1,271 - 37.2274 - 25.4997 - 42.6\<0.0001Anti-arrhythmics (45/60)1,394 - 41.5264 - 25.11,130 - 48.90.01Defibrillation (84/63)3,317 - 99.91,013 - 99.92,304 - 99.91.00No. of defibrillations[c](#tbl2fnB){ref-type="table-fn"}3 (1,9)2 (1,8)4 (1,10)\<0.0001**Delay, minutes:**Collapse to start of CPR (131/265)2 (0,12)1 (0,8)3 (0,15)\<0.0001Collapse to first defibrillation[c](#tbl2fnB){ref-type="table-fn"} (115/248)13 (6,24)11 (5,19)14 (7,26)\<0.0001Call for EMS to EMS arrival (199/346)8 (4,19)7 (3,15)9 (4,20)\<0.0001**Survival at 30 days**1,098--31.71,098 - 1000 - 0[^1][^2][^3][^4]Table 3Comparison of patients with and without complete data.Table 3**All patients (*n*=12012)Complete data*p* valueYes (*n*=8193)No (*n*=3819)Year of OHCA**\<0.0001\#201119.116.823.8**201219.018.619.8201320.320.619.7201420.019.820.4201521.624.116.3OHCA during daytime 08--20** (941)\*66.065.068.80.0002**Age** (years)72 (52,88)72 (52,87)72 (51,88)0.92**Female sex**31.731.631.80.90**VF/VT as initial arrhythmia** (433)30.030.129.50.50**OHCA at home** (7)70.671.768.0\<0.0001**CPR before arrival of EMS** (57)71.272.269.10.0006**Mechanical chest compression** (881)37.741.327.8\<0.0001**Cardiac etiology** (561)70.770.272.10.04**Treatment**Adrenalin (142)83.084.779.1\<0.0001Intubation (104)36.633.443.7\<0.0001Anti-arrhythmics (283)16.217.413.5\<0.0001**Delay** (minutes)Collapse to start of CPR (1453)4 (0,16)3 (0,15)5 (0,19)\<0.0001Call for EMS to EMS arrival (2084)10 (4,21)10 (4,21)10 (4,22)0.46**Survival at 30 days**All patients13.312.415.3\<0.0001Patients found in ventricular fibrillation31.731.232.80.35Patients with other initial arrhythmia4.24.33.90.54[^5][^6][^7]Table 4Associations between missingness and other baseline characteristics, CCI and survival in all patients.Table 4Missingness ofBaseline characteristicsYear of OHCAOHCA during day-timeAgeSexInitial rhythmOHCA at homeCPR before arrival of EMSMechanical CCCardiac aeti-logyAdrenalinIntubationAntiarrhythmicsOHCA to start of CPRCall for EMS to arrivalCC indexAlive at 30 daysOHCA during daytimeXNA------X--XXXX----X----Initial rhythmXX----NAXXXXXXXX----XOHCA at homeX--------NA--------------------CPR before arrival of EMS------X----NA----X------------Mechanical CCX----------XNAX--XXX--X--Cardiac aetiologyXX----XX--XNAX--------X--Adrenalin--X------X--X--NAXXX----XIntubation----X--XX--X--XNAX------XAnti-arrhythmicsXX----XX----XXXNAX----XCA to start of CPRX----------XXXX----NAX----Call for EMS to EMS arrivalXX----XX--XX--XXXNAX--[^8][^9][^10]Fig. 1Patients with any ROSC and relation to comorbidity (*n*=4,612). \* The comorbidities of moderate or severe liver disease and AIDS/HIV were not analyzed in the specific comorbidity conditions above, due to low prevalence (0.6% and 0.1%, respectively).Fig. 1Fig. 2Patients with ROSC at hospital admission and relation to comorbidity (*n*=3,690). \* The comorbidities of moderate or severe liver disease and AIDS/HIV were not analyzed in the specific comorbidity conditions above, due to low prevalence (0.6% and 0.1%, respectively).Fig. 2Fig. 3Patients with non-missing data on all baseline characteristics (*n*=8,193). (1014 (12.4%) patients alive at 30 days). \* The comorbidities of moderate to severe liver disease and AIDS/HIV were not analyzed in the specific comorbidity conditions above, due to low prevalence (0.6% and 0.0%, respectively).Fig. 3Fig. 4Patients for whom comorbidity conditions were identified 3--5 years before OHCA. \* The comorbidities of moderate or severe liver disease and AIDS/HIV were not analyzed in the specific comorbidity conditions above, due to low prevalence (0.2% and 0.1%, respectively).Fig. 4Fig. 5Patients for whom comorbidity was first identified within 1 year before OHCA. \* The comorbidities of moderate or severe liver disease and AIDS/HIV were not analyzed in the specific comorbidity conditions above, due to low prevalence (0.2% and 0.0%, respectively).Fig. 5Fig. 6Comorbidity conditions within 1 year before OHCA irrespective of identification 1--5 years before OHCA. \* The comorbidities of moderate or severe liver disease and AIDS/HIV were not analyzed in the specific comorbidity conditions above, due to low prevalence (0.3% and 0.0%, respectively).Fig. 6

2. Experimental design, materials, and methods {#s0010}
==============================================

We conducted an analysis of data from the Swedish Registry for Cardiopulmonary Resuscitation (SRCR) which was collected between 2011 and 2015. We linked the data from SRCR with data from the National Patient Registry (NPR). The NPR includes data on diagnoses and surgical procedure codes from hospitals and specialist clinics [@bib3]. We had data on health disorders during the five years preceding the OHCA. We measured comorbidity with CCI as shown in [Table 1](#t0005){ref-type="table"}. If the patient had any mention of an ICD-10 code listed in the NPR which was included in the category definition of CCI, the patient would get a weight point with the maximum possible score of 29.

3. Study design {#s0015}
===============

We performed a nationwide population-based cohort study of patients with bystander witnessed OHCA which was designed to evaluate if there were any association between comorbidity and outcome. We included all cases with bystander-witnessed OHCA who were ≥18 years of age. Unwitnessed and cases only witnessed by Emergency Medical Service (EMS) were excluded. For details, see Ref. [@bib1].

4. Statistical analysis {#s0020}
=======================

We used logistic regression and made adjustments for year of OHCA, age, sex, initial rhythm, location, bystander cardiopulmonary resuscitation (CPR), mechanical chest compression, aetiology, adrenalin treatment, intubation, anti-arrhytmics, time to CPR and EMS response time. Fisher׳s exact test was used to test for difference between groups regarding dichotomous variables and Mann-Whitney U test for ordered/continuous variables in the baseline characteristics. We used multiple imputation for the multivariable analysis and the missing data were assumed to be missing at random (MAR). To exclude that the missing data pattern were missing completely at random (MCAR) we compared cases with no missing data with incomplete cases ([Table 3](#t0015){ref-type="table"}) and found several major differences. The assumption of a MAR pattern was indicated to be valid by examination of the associations between missingness of each variable with other variables ([Table 4](#t0020){ref-type="table"}). We analysed also complete cases without multiple imputation ([Fig. 3](#f0015){ref-type="fig"}). Outcome endpoint was not imputed and thus only patients with any ROSC or ROSC at hospital admission were included in the analysis in [Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}.
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Supplementary material..

Transparency data associated with this article can be found in the online version at <https://doi.org/10.1016/j.dib.2018.11.010>.

[^1]: Data are presented as number - percentage (%) or median (10th, 90th percentile).

[^2]: Year of OHCA as an ordered variable.

[^3]: Number of patients with missing information (of those alive/not alive at 30 days).

[^4]: Of those defibrillated (*n*=1,013/2,304).

[^5]: Results presented as percentage (%) or median (10th, 90th percentile).

[^6]: \#Year of OHCA as an ordered variable.

[^7]: \*Number of patients with missing information.

[^8]: X=an association found using Fisher׳s exact test or Mann-Whitney U test (*p*\<0.05).

[^9]: \-\-\--=no association (*p*\>0.05).

[^10]: NA=not applicable.
